Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer

BMC Genetics

Volumn 4, Issue , 2003, Pages

  Hirunsatit, Rungnapa ^a   Kongruttanachok, Narisorn ^a   Shotelersuk, Kanjana ^a   Supiyaphun, Pakpoom ^a   Voravud, Narin ^a   Sakuntabhai, Anavaj ^b   Mutirangura, Apiwat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE; COMPLEMENT RECEPTOR; CYTOSINE; GUANINE; NUCLEOTIDE; SECRETORY COMPONENT; THYMINE; VALINE; VIRUS RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; DNA;

ARTICLE; CANCER RISK; CHINESE; COMPLEX FORMATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NASOPHARYNX CANCER; POPULATION RISK; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THAILAND; TRANSCYTOSIS; CASE CONTROL STUDY; CHEMISTRY; GENE FREQUENCY; GENETICS; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK;

HUMAN HERPESVIRUS 4;

CASE-CONTROL STUDIES; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MUTATION, MISSENSE; NASOPHARYNGEAL NEOPLASMS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT 3D; RECEPTORS, POLYMERIC IMMUNOGLOBULIN;

EID: 0037458093     PISSN: 14712156     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2156-4-3     Document Type: Article

References (30)

1. Mutirangura A Molecular mechanisms of nasopharyngeal carcinoma development. Research Advances and Research Updates in Medicine 2000, 1:18-27
2. McDermott AL, Dutt SN and Watkinson JC The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol 2001, 26:82-92
3. Cheung F, Pang SW, Hioe F, Cheung KN, Lee A and Yau TK Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity. Cancer 1998, 83:1069-1073
4. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P and Voravud N Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 1997, 76:770-776
5. Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995, 333:693-698
6. Jeannel D, Hubert A, de Vathaire F, Ellouz R, Camoun M, Ben Salem M, Sancho-Garnier H and de-The G Diet, living conditions and nasopharyngeal carcinoma in Tunisia - a case-control study. Int J Cancer 1990, 46:421-425
7. Yu MC, Huang TB and Henderson BE Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer 1989, 43:1077-1082
8. Simons MJ, Wee GB, Chan SH and Shanmugaratnam K Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975, 1:142-143
9. Ren EC and Chan SH Human leucocyte antigens and nasopharyngeal carcinoma. Clin Sci (Lond) 1996, 91:256-258
10. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS and Chhabra SK CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997, 89:1207-1212
11. Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N, Poovorawan Y and Mutirangura A Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001, 1:4
12. Voravud N Cancer in the Far East. In Treatment of Cancer (Edited by: Sikora K and Halman KE) Chapman and Hall Medical: London 1990, 887-894
13. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA and Fearon DT Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 1984, 81:4510-4514
14. Chang Y, Tung CH, Huang YT, Lu J, Chen JY and Tsai CH Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 1999, 73:8857-8866
15. Imai S, Nishikawa J and Takada K Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998, 72:4371-4378
16. Shao X, He Z, Chen Z and Yao K Expression of an Epstein-Barrvirus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells. Int J Cancer 1997, 71:750-755
17. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M and Tuomanen E The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102:827-837
18. Norderhaug IN, Johansen FE, Schjerven H and Brandtzaeg P Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 1999, 19:481-508
19. Gan YJ, Chodosh J, Morgan A and Sixbey JW Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J Virol 1997, 71:519-526
20. Reich V, Mostov K and Aroeti B The basolateral sorting signal of the polymeric immunoglobulin receptor contains two functional domains. J Cell Sci 1996, 109:2133-2139
21. Lin CT, Lin CR, Tan GK, Chen W, Dee AN and Chan WY The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997, 150:1745-1756
22. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ and Yang CS Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001, 345:1877-1882
23. Tabor HK, Risch NJ and Myers RM Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature Reviews Genetics 2002, 3:391-397
24. Fujisaku A, Harley JB, Frank MB, Gruner BA, Frazier B and Holers VM Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem 1989, 264:2118-2125
25. Krajci P, Kvale D, Tasken K and Brandtzaeg P Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor). Eur J Immunol 1992, 22:2309-2315
26. Dracopoli N, Haines J and Korf B Current protocol in human genetic. John & Sons, New york. 2000,
27. Spurdle A, Hopper J and Dite G CYP17 Promoter Polymorphism and Breast Cancer in Australian Woman Under Age Forty Years. Journal of the National Cancer Institute 2000, 92:1674-1681
28. Zhao JH, Curtis D and Sham PC Model-free analysis and permutation tests for allelic associations. Hum Hered 2000, 50:133-139
29. Banting G, Brake B, Braghetta P, Luzio JP and Stanley KK Intracellular targetting signals of polymeric immunoglobulin receptors are highly conserved between species. FEBS Lett 1989, 254:177-183
30. Hughes G, S F, L-A S, AJ R, HR M and J-C J Human free secretory component of the polymeric immunoglobulin receptor. FEBS Lett 1997, 410:443-446